# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.

> **NCT06147544** · PHASE1,PHASE2 · COMPLETED · sponsor: **PegBio Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** PB-718
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06147544
- **Lead sponsor:** PegBio Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-06
- **Primary completion:** 2024-04-16
- **Final completion:** 2024-04-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06147544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06147544, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06147544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*